# US 2026/0076887 A1 · Personal care compositions containing tailored monolipid-rhamnolipids and sulfate-free surfactants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076887 A1
- Document ID: US20260076887A1
- Status: Published application
- Kind: A1
- Application number: 19/397,151
- Filed: 2025-11-21
- Published: 2026-03-19
- Earliest claimed: 2024-02-26
- Assignees: The Procter & Gamble Company
- Applicants: The Procter & Gamble Company
- Inventors: Howard David HUTTON, III; Isoken Omosefe IGWEKALA-NWEKE; John Samuel KENNEY; Debora W. Chang; Sumanth Narahari Jamadagni
- Web page: https://patentgrep.com/patent/US20260076887A1

## CPC

- A61K 8/604: {Alkylpolyglycosides; Derivatives thereof, e.g. esters}
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/442: {substituted by amido group(s)}
- A61K 8/466: {containing sulfonic acid derivatives; Salts}
- A61K 8/602: {Glycosides, e.g. rutin}
- A61Q 5/02: Preparations for cleaning the hair
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61Q 19/10: Washing or bathing preparations
- A61K 2800/596: Mixtures of surface active compounds
- A61K 2800/75: Anti-irritant
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A personal care composition, comprising a mono-rhamno-mono-lipid, a di-rhamno-mono-lipid, a co-surfactant and a carrier. The combination of rhamno-mono-lipids and co-surfactants in a personal cleansing composition reduces the eye irritation potential during application.

## Claims

### Claim 1

A personal care composition comprising:
a) a mono-rhamno-mono-lipid of structure I:
b) a di-rhamno-mono-lipid of structure II:
wherein:
Rha is rhamnose,
Cx is a C4-C22 alkyl, aryl, heteroalkyl, heteroaryl, unsaturated alkenyl, or unsaturated heteroalkenyl, and
M is a OH, alkyl, heteroalkyl, aryl, heteroaryl, hetero arylalkyl, arylalkyl, tauryl, O—X+, wherein X+ is a cation, or O—R1, wherein R1 is selected from an alkyl, branched alkyl, and cyclic alkyl, and stereoisomers thereof;
wherein the personal care composition comprises a Log EC50 value of greater than about 0.3.

### Claim 2 (depends on 1)

The personal care composition of claim 1, wherein the composition has a viscosity in the range of 15 to 50 cps.

### Claim 3 (depends on 1)

The personal care composition of claim 1, wherein the composition has a pH in the range of 6.8 to 7.4.

### Claim 4 (depends on 1)

The personal care composition of claim 1, further comprising a co-surfactant chosen from acyl taurate surfactant, an N-alkyl acyl taurate surfactant, an alpha olefin sulfonate surfactant, betaine, sodium lauroamphoacete, an amidopropyl hydroxysultaine, an alkyl glucoside, an amphodiacetate, an ethoxylated alkyl sulfosuccinate, a glutamate, and combinations thereof.

### Claim 5 (depends on 4)

The personal care composition of claim 4, wherein the acyl taurate surfactant comprises lauroyl taurate or a salt thereof.

### Claim 6 (depends on 4)

The personal care composition of claim 4, wherein the olefin sulfonate is a C14-16 alpha olefin sulfonate.

### Claim 7 (depends on 4)

The personal care composition of claim 4, wherein the N-alkyl acyl taurate surfactant comprises lauroyl methyl taurate or a salt thereof.

### Claim 8 (depends on 4)

The personal care composition of claim 4, wherein the betaine surfactant is cocobetaine, cocamidopropyl betaine and mixtures thereof.

### Claim 9 (depends on 4)

The personal care composition of claim 4, wherein the total amount of mono-rhamno-mono-lipid of structure I and di-rhamno-mono-lipid of structure II present is about 0.5 wt. % to about 30 wt. %, and wherein the co-surfactant is present at a level of about 0.5 wt. % to about 30 wt. %.

### Claim 10 (depends on 4)

The personal care composition of claim 4, wherein the total amount of surfactant present in the composition is from about 5 wt. % to about 50 wt. %.

### Claim 11 (depends on 4)

The personal care composition of claim 4, wherein the ratio of the total combined amount of mono-rhamno-mono-lipid of structure I and di-rhamno-mono-lipid of structure II to the total amount of co-surfactant is from about 10:1 to about 1:10.

### Claim 12 (depends on 1)

The personal care composition of claim 1, wherein a ratio of the total amount of mono-rhamno-mono-lipid to the total amount of di-rhamno-mono-lipid is 10:1 to 1:10.

### Claim 13 (depends on 1)

The personal care composition of claim 1, wherein the composition has a Lather Height of greater than 2.5 cm according to the Blender Lather Height (oil) method.

### Claim 14 (depends on 1)

The personal care composition of claim 1, wherein the composition further comprises a beta hydroxy fatty acid having a formula III:

### Claim 15 (depends on 14)

The personal care composition of claim 14, wherein the beta hydroxy fatty acid is selected from 3-hydroxytetradecanoic acid, 3-hydroxyhexadecanoic acid, 3-hydroxydeceneoic acid, 3-hydroxytetradecenoic acid, 3-hydroxydodecanoic acid, 3-hydroxydodecenoic acid, 3-hydroxyoctanoic acid, 3-hydroxydodec-dienoic acid, and 3-hydroxydecaneoic acid.

### Claim 16 (depends on 1)

The personal care composition of claim 1, wherein at least one of the mono-rhamno-mono-lipid of structure I and di-rhamno-mono-lipid of structure II is present at 25 wt % or more, based on the total weight of rhamnolipids.

### Claim 17 (depends on 1)

The personal care composition of claim 1, wherein the total amount of the mono-rhamno, mono-lipid of structure I and the di-rhamno, mono-lipid of structure II is 80 wt % or more, based on the total weight of rhamnolipids.

### Claim 18 (depends on 1)

The personal care composition of claim 1, wherein the composition comprises less than 25 wt % of a rhamno di-lipid, based on the total weight of rhamnolipids in the composition.

### Claim 19 (depends on 1)

The personal care composition of claim 1, wherein the mono-rhamno mono-lipid is selected from 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexadecanoic acid, 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)octenoic acid, 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)decenoic acid, 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)octanoic acid, 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetradecanoic acid, 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)decanoic acid, 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)dodecanoic acid, 3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)dodecen-dienoic acid, and stereoisomers thereof and wherein the di-rhamno mono-lipid is selected from 3-(((2R,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-(((2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)hexadecanoic acid, 3-(((2R,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-(((2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)tetradecanoic acid, 3-(((2R,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-(((2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)decenoic acid, 3-(((2R,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-(((2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)tetradecenoic acid, 3-(((2R,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-(((2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)decanoic acid, 3-(((2R,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-(((2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)octanoic acid, and 3-(((2R,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-(((2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)dodecanoic acid, and stereoisomers thereof.

### Claim 20 (depends on 1)

A method for cleaning hair and scalp while reducing the eye irritation potential comprising:
(a) providing the personal care composition of claim 1;
(b) dispensing the personal care composition into a palm or cleaning implement;
(c) applying the personal care composition onto wet hair and massaging the personal care composition across the hair and scalp; wherein the shampoo composition is diluted forming a lyotropic liquid crystal coacervate that is deposited onto the hair; and
(d) rinsing the personal care composition from the hair and scalp.
